Bullish Case: AVIV sits at $81.89 after +23.5% one-year and +49.6% two-year gains, backed by the return surface's dense likelihood mass at moderate positive returns for 0.5–1.5-year holds. Global value rotation, ex-US profitability-tilted holdings, quarterly dividends, and steady sentiment ('strategically patient') support continued single-digit-to-teens gains if FX and non-US cyclicals stay firm. Helium's own model prints +2.34% bullish.

Bearish Case: The +55.9% two-year advance is extended and price is -1.5% over the past month — momentum has stalled. Mean reversion risk is real. SPY's IV surface shows fat downside-strike vol (~35 at deep puts vs ~13 at spot over 250 days), signaling expensive tail insurance and an asymmetric risk regime. Dollar strength or risk-off could trigger a 10-20% drawdown toward low-$70s.

Potential Outcomes:

1. Modest gain (40%): +3–12% in 12m (~$84–$92); return-surface mode + Helium +2.34% forecast align.
2. Flat (30%): -3% to +3% (~$79–$84); month-long stall and momentum fade suggest range.
3. Pullback (18%): -5% to -15% (~$70–$78); elevated downside IV skew + extended two-year run.
4. Rally (8%): >+15% (>$94) on FX tailwind/global value re-rating.
5. Severe shock (4%): <-15% (<$70) on geopolitical/FX shock.

September 23, 2026